Health News Archive - February 03, 2010
HOUSTON, Feb. 3 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the third quarter ended January 22, 2010 of its fiscal year ending April 30, 2010 on Wednesday, February 17, 2010 at 5:00 PM EST.
WINSTON-SALEM, N.C., Feb.
VIENNA, Va., Feb. 3 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE AMEX: CVM) announced that Geert Kersten, Chief Executive Officer, will be presenting at the 2010 BIO CEO & Investor Conference.
LOS ANGELES, Feb. 3 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on Pro-Pharmaceuticals, Inc. (OTC Bulletin Board: PRWP) with a twelve month target price of $1.95.
CHICAGO, Feb. 3 /PRNewswire/ -- A new survey(1) shows that given today's economy, most Americans (98%) are looking for more value from the things they buy.
For the first time, researchers from the University of Pennsylvania School of Medicine have found that three different degenerative brain disorders are linked by a toxic form of the same protein.
HERSHEY, Pa., Feb. 3 /PRNewswire-FirstCall/ -- AT&T* is working with Penn State Milton S. Hershey Medical Center to provide complimentary AT&T Wi-Fi access in hospital patient areas.
COLUMBIA, Md., Feb. 3 /PRNewswire/ -- Resolution Health, Inc.,(RHI) an industry-leading personal health care guidance company and subsidiary of WellPoint, Inc., developed 25 of the 70 measures recently endorsed by the National Quality Forum (NQF).
GENEVA, February 3 /PRNewswire/ -- Viroblock SA, a start-up dedicated to developing and commercializing a new generation of anti-viral products, today announced that Dr.
NIH-funded study finds abnormalities in brain region that regulates breathing, sleep.
- A person in a secondary role, specifically the second most important character (after the protagonist).